Risks and Benefits of Continuing Renin-Angiotensin-Aldosterone System Inhibitors in Critically-Ill Patients.Ruey-Hsing Chou,Shang-Feng Yang,Po-Hsun HuangActa Cardiologica Sinica(2024)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要